Thiazolidinediones News and Research

RSS
Thiazolidinediones are adjunctive therapies for diabetes mellitus (type 2) and related diseases.
Study reveals mechanisms behind Thiazolidinediones used to treat type 2 diabetes

Study reveals mechanisms behind Thiazolidinediones used to treat type 2 diabetes

Scientists have discovered how C-reactive protein is able to access endothelial cells

Scientists have discovered how C-reactive protein is able to access endothelial cells

Insulin resistance drug with anti-inflammatory effects reduces risk factors

Insulin resistance drug with anti-inflammatory effects reduces risk factors

Study shows why thiazolidinediones cause edema and helps understand role of kidneys in hypertension

Study shows why thiazolidinediones cause edema and helps understand role of kidneys in hypertension

Researchers describe emerging strategy for prevention, early treatment of Type 2 diabetes

Researchers describe emerging strategy for prevention, early treatment of Type 2 diabetes

Keeping fit lowers C-Reactive protein in people with metabolic syndrome

Keeping fit lowers C-Reactive protein in people with metabolic syndrome

Rosiglitazone helps boost the effectiveness of a treatment for opening clogged arteries

Rosiglitazone helps boost the effectiveness of a treatment for opening clogged arteries

Combination treatment may help type 2 diabetes patients

Combination treatment may help type 2 diabetes patients

Study of three treatments of type 2 diabetes in children and teens has begun in US

Study of three treatments of type 2 diabetes in children and teens has begun in US